JUUL Labs is pleased to announce our purchase of the 123 Mission Street building in San Francisco, which will serve as additional office space to accommodate our rapidly growing team. We have always been a proud San Francisco-based company, and remain committed to serving the community as we focus on helping adult smokers switch from combustible cigarettes — the leading cause of preventable death — and combating underage use.
September 3, 2020
Today, Juul Labs announced additional steps to further secure our business for the long term and to ultimately end the era of the combustible cigarette.
August 18, 2020
Juul Labs today announced that it received notice from the Food and Drug Administration (FDA) that the company’s Premarket Tobacco Product Applications (PMTA) will enter the substantive review phase.
Juul Labs recently filed six trademark enforcement actions in several states across the U.S. as part of its global enforcement program, directed at disrupting the illicit trade of black-market vapor products.